Switzer TV

In this week’s Switzer Investing TV, Paul Rickard sits down with chartist and market analyst Mike Gable to break down the big ideas driving today’s bull market — from rare earths and uranium to the comeback stories in healthcare and banking.

They look at what’s powering the ASX200’s latest rally, whether the US market still has room to run, and which sectors could surprise next. Plus, Gable shares how he’s positioning in gold, why CSL might finally be turning the corner, and where he sees upside in Macquarie.

In this episode:

• The ASX200’s breakout — sustainable or overdone?

• Rare earths vs lithium: is history repeating?

• Uranium and gold: the commodities back in focus

• Has CSL bottomed, and what’s next for healthcare?

• The banks and Macquarie — are they about to run again?

If you’re looking for market insight that blends technical charts with fundamental reasoning, this is a must-watch for every Australian investor.

Hosted by Paul Rickard | Guest: Mike Gable, Managing Director, Fairmont Equities.

Switzer Investing TV | 20 Oct 2025: Are rare earths about to get the Lithium hosing? Plus: Can US shares run even higher, and will the ASX200 follow?

We break down the big ideas driving today’s bull market: from rare earths and uranium to the comeback stories in healthcare and banking.

More videos

Mad about Money

Peter Switzer shares his thoughts on the major current affairs impacting financial markets and the economy.

Series:
Is mobile phone use associated with an increased risk for brain cancer? | The Check Up

There have always been rumours on whether mobile phones are really linked with an increased risk for brain cancer. In this week's episode, Dr Ross looks at certain studies to assess this claim.

Series:
Michael Wayne on these stocks & more; TYR, APX, DDR + What's going on in the housing market?

Peter Switzer is joined by Michael Wayne of Medallion Financial, ST Wong of Prime Value, and CEO of Rate Money, Ryan Gair.

Series:
Are we heading for a recession? + Expert analysis on these 7 stocks!

Peter Switzer is joined by Michael Gable of Fairmont Equities, and Marcus Bogdan of Blackmore Capital.

Series:
A promising male contraception pill with zero effects on hormones?! | The Check Up

Currently, the only form of male contraception is a condom and a vasectomy. However, through certain studies and research conducted with mice, we may soon see a contraception pill for males with no hormonal effects.

Series:
Mad about Money

3 reasons why Dr Phil better be careful about raising interest rates & could stocks slide tomorrow?

Series:
5 quality stocks; GMG, ANZ, XRO, JBH & S32 + Should we fear the fed interest rate decision?

Peter Switzer is joined by Jun Bei Liu of Tribeca Investment Partners, Anthony Doyle from Firetrail Investments and Paul Rickard is joined by Angus Moore from Proptrack.

Series:
What is immunotherapy and how does it fight cancer? | The Check Up

Dr Ross explains whether immunotherapy could be the new approach that could lead to an effective treatment for various types of cancer.

Series:
4 mid-cap stocks for your portfolio + How do you renovate or build and stay within your budget?

Paul Rickard is joined by Rudi Filapek-Vandyck of FNArena, Raymond Chan of Morgans, and Anna Porter from Suburbanite.

Series:
Mad about Money

US inflation disappoints & Wall Street tanks + Star Entertainment: 'Unfit to hold casino license'.

Series:
Why are copper, nickel and lithium stocks on the rise? + 3 growth companies; DGL, PPE & SMP

Paul Rickard is joined by Michael Wayne of Medallion Financial, Adam Dawes of Shaw and Partners, and Ron Shamgar of Tamim Asset Management.

Series:
Can a high dose of vitamin E really cause death? | The Check Up

Dr Ross has a look at whether a high dose of vitamin E can actually lead to death, as some studies show.

Series:
1 9 10 11 12 13 51

Fill in the form below to subscribe to Switzer Daily and get our latest articles, videos and podcasts sent straight to your inbox

Get the latest financial, business, and political expert commentary delivered to your inbox.

When you sign up, we will never give away or sell or barter or trade your email address.

And you can unsubscribe at any time!
Subscribe
© 2006-2021 Switzer. All Rights Reserved. Australian Financial Services Licence Number 286531. 
shopping-cartphoneenvelopedollargraduation-cap linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram